ALDH2 and cardiovascular disorder: Targeting ALDH2 may simultaneously block oxidative damage and microcirculatory dysfunction, providing a novel therapeutic strategy for cardiovascular diseases and foundational evidence for optimizing post-MI ventricular remodeling treatments.